Methods for PTEN in stem cells and cancer stem cells

Methods in Molecular Biology

Volumn 1388, Issue , 2016, Pages 233-285

  Schubbert, Suzanne ^a   Jiao, Jing ^a   Ruscetti, Marcus ^a   Nakashima, Jonathan ^a   Wu, Shumin ^a   Lei, Hong ^b   Xu, Qinzhi ^b   Yi, Wenkai ^b   Zhu, Haichuan ^b   Wu, Hong ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Peking University   (China)

Author keywords

Cancer stem cells; ES cell; HSC; Leukemia initiating cell; NSC; Prostate cancer stem cell; PTEN; Stem cell

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PYRONINE;

CANCER STEM CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL SUBPOPULATION; COLONY FORMING CELL; EMBRYONIC STEM CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN VITRO STUDY; LEUKEMIA CELL; NEURAL STEM CELL; NONHUMAN; PROSTATE CELL; STEM CELL; STEM CELL EXPANSION; STEM CELL SELF-RENEWAL; ANIMAL; CELL CULTURE; CELL CULTURE TECHNIQUE; CHEMISTRY; METABOLISM;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; EMBRYONIC STEM CELLS; HUMANS; NEOPLASTIC STEM CELLS; PTEN PHOSPHOHYDROLASE; STEM CELLS;

EID: 84990201033     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3299-3_15     Document Type: Chapter

References (60)

1. Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci U S A 96(11):6199-6204
2. Stiles B, Gilman V, Khanzenzon N, Lesche R, Li A, Qiao R, Liu X, Wu H (2002) Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis. Mol Cell Biol 22(11):3842-3851
3. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X, Wu H (2003) PTEN tumor suppressor regulates p53 protein levels and activity through phosphatasedependent and-independent mechanisms. Cancer Cell 3(2):117-130
4. Di Cristofano A, Pesce B, Cordon-Cardo C, PandolfiPP (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet 19(4):348-355. doi: 10.1038/1235
5. Lindgren AG, Natsuhara K, Tian E, Vincent JJ, Li X, Jiao J, Wu H, Banerjee U, Clark AT (2011) Loss of Pten causes tumor initiation following differentiation of murine pluripotent stem cells due to failed repression of Nanog. PLoS One 6(1), e16478. doi: 10.1371/journal.pone.0016478
6. Morrison SJ, Uchida N, Weissman IL (1995) The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 11:35-71. doi: 10.1146/annurev.cb.11.110195.000343
7. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441(7092):475-482
8. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, Wu H, Li L (2006) PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441(7092):518-522
9. Guo W, Lasky JL, Chang CJ, Mosessian S, Lewis X, Xiao Y, Yeh JE, Chen JY, Iruela-Arispe ML, Varella-Garcia M, Wu H (2008) Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature 453(7194):529-533. doi: 10.1038/nature06933
10. Tesio M, Oser GM, Baccelli I, Blanco-Bose W, Wu H, Gothert JR, Kogan SC, Trumpp A (2013) Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization. J Exp Med 210(11):2337-2349. doi: 10.1084/jem.20122768
11. Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H, Liu X, Wu H (2002) Cre/loxPmediated inactivation of the murine Pten tumor suppressor gene. Genesis 32(2): 148-149
12. Magee JA, Ikenoue T, Nakada D, Lee JY, Guan KL, Morrison SJ (2012) Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression. Cell Stem Cell 11(3):415-428. doi: 10.1016/j.stem.2012.05.026
13. Lee JY, Nakada D, Yilmaz OH, Tothova Z, Joseph NM, Lim MS, Gilliland DG, Morrison SJ (2010) mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion. Cell Stem Cell 7(5):593-605. doi: 10.1016/j.stem.2010.09.015
14. Guo W, Schubbert S, Chen JY, Valamehr B, Mosessian S, Shi H, Dang NH, Garcia C, Theodoro MF, Varella-Garcia M, Wu H (2011) Suppression of leukemia development caused by PTEN loss. Proc Natl Acad Sci U S A 108(4):1409-1414. doi: 10.1073/pnas.1006937108
15. Schubbert S, Cardenas A, Chen H, Garcia C, Guo W, Bradner J, Wu H (2014) Targeting the MYC and PI3K pathways eliminates leukemiainitiating cells in T-cell acute lymphoblastic leukemia. Cancer Res 74(23):7048-7059. doi: 10.1158/0008-5472.CAN-14-1470
16. Kriegstein A, Alvarez-Buylla A (2009) The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 32:149-184. doi: 10.1146/annurev.neuro.051508.135600
17. Galvez-Contreras AY, Quinones-Hinojosa A, Gonzalez-Perez O (2013) The role of EGFR and ErbB family related proteins in the oligodendrocyte specification in germinal niches of the adult mammalian brain. Front Cell Neurosci 7:258. doi: 10.3389/fncel.2013.00258
18. Gregorian C, Nakashima J, Le Belle J, Ohab J, Kim R, Liu A, Smith KB, Groszer M, Garcia AD, Sofroniew MV, Carmichael ST, Kornblum HI, Liu X, Wu H (2009) Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis. J Neurosci 29(6):1874-1886. doi: 10.1523/JNEUROSCI.3095-08.2009
19. Groszer M, Erickson R, Scripture-Adams DD, Dougherty JD, Le Belle J, Zack JA, Geschwind DH, Liu X, Kornblum HI, Wu H (2006) PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci U S A 103(1): 111-116
20. Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A, Zack JA, Kornblum HI, Liu X, Wu H (2001) Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294(5549):2186-2189
21. Yue Q, Groszer M, Gil JS, Berk AJ, Messing A, Wu H, Liu X (2005) PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development 132(14):3281-3291. doi: 10.1242/dev.01891
22. English HF, Santen RJ, Isaacs JT (1987) Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11(3):229-242
23. Bonkhoff H, Remberger K (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28(2):98-106. doi: 10.1002/(SICI)1097-0045(199602)28:2<98::AIDPROS4>3.0.CO;2-J
24. Tsujimura A, Koikawa Y, Salm S, Takao T, Coetzee S, Moscatelli D, Shapiro E, Lepor H, Sun TT, Wilson EL (2002) Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 157(7):1257-1265. doi: 10.1083/jcb.200202067
25. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117(Pt 16):3539-3545. doi: 10.1242/jcs.01222
26. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331(6024):1559-1564. doi: 10.1126/science.1203543
27. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scardino PT, Sander C, Sawyers CL, Gerald WL (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1):11-22. doi: 10.1016/j.ccr.2010.05.026
28. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H (2003) Prostatespecific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4(3):209-221
29. Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, Wu H (2009) Lin-Sca-1 + CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 69(22):8555-8562. doi: 10.1158/0008-5472.CAN-08-4673
30. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON (2010) Identification of a cell of origin for human prostate cancer. Science 329(5991):568-571. doi: 10.1126/science.1189992
31. Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, Gleave M, Wu H (2012) Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res 72(7):1878-1889. doi: 10.1158/0008-5472.CAN-11-3132
32. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON (2008) Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A 105(52):20882-20887. doi: 10.1073/pnas.0811411106
33. Choi SY, Gout PW, Collins CC, Wang Y (2012) Epithelial immune cell-like transition (EIT): a proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers. Differentiation 83(5):293-298. doi: 10.1016/j.diff.2012.02.005
34. Knoechel B, Roderick JE, Williamson KE, Zhu J, Lohr JG, Cotton MJ, Gillespie SM, Fernandez D, Ku M, Wang H, Piccioni F, Silver SJ, Jain M, Pearson D, Kluk MJ, Ott CJ, Shultz LD, Brehm MA, Greiner DL, Gutierrez A, Stegmaier K, Kung AL, Root DE, Bradner JE, Aster JC, Kelliher MA, Bernstein BE (2014) An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat Genet. doi: 10.1038/ng.2913
35. Valamehr B, Jonas SJ, Polleux J, Qiao R, Guo S, Gschweng EH, Stiles B, Kam K, Luo TJ, Witte ON, Liu X, Dunn B, Wu H (2008) Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies. Proc Natl Acad Sci U S A 105(38):14459-14464. doi: 10.1073/pnas.0807235105
36. Morrison SJ, Lagasse E, Weissman IL (1994) Demonstration that Thy(lo) subsets of mouse bone marrow that express high levels of lineage markers are not significant hematopoietic progenitors. Blood 83(12):3480-3490
37. Spangrude GJ, Heimfeld S, Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241(4861):58-62
38. Christensen JL, Weissman IL (2001) Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A 98(25):14541-14546. doi: 10.1073/pnas.261562798
39. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121(7):1109-1121. doi: 10.1016/j.cell.2005.05.026
40. Yilmaz OH, Kiel MJ, Morrison SJ (2006) SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity. Blood 107(3):924-930. doi: 10.1182/blood-2005-05-2140
41. Lemieux ME, Eaves CJ (1996) Identification of properties that can distinguish primitive populations of stromal-cell-responsive lympho-myeloid cells from cells that are stromal-cell-responsive but lymphoid-restricted and cells that have lympho-myeloid potential but are also capable of competitively repopulating myeloablated recipients. Blood 88(5):1639-1648
42. Song MS, Salmena L, PandolfiPP (2012) The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13(5):283-296. doi: 10.1038/nrm3330
43. Shen H, Boyer M, Cheng T (2008) Flow cytometry-based cell cycle measurement of mouse hematopoietic stem and progenitor cells. Methods Mol Biol 430:77-86. doi: 10.1007/978-1-59745-182-6_5
44. Szilvassy SJ, Humphries RK, Lansdorp PM, Eaves AC, Eaves CJ (1990) Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci U S A 87(22): 8736-8740
45. Till JE, Mc CE (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14:213-222
46. Smith LG, Weissman IL, Heimfeld S (1991) Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A 88(7):2788-2792
47. Gage GJ, Kipke DR, Shain W (2012) Whole animal perfusion fixation for rodents. J Vis Exp JoVE (65). doi: 10.3791/3564
48. Leong KG, Wang BE, Johnson L, Gao WQ (2008) Generation of a prostate from a single adult stem cell. Nature 456(7223):804-808. doi: 10.1038/nature07427
49. Xin L, Lawson DA, Witte ON (2005) The Sca-1 cell surface marker enriches for a prostateregenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A 102(19):6942-6947. doi: 10.1073/pnas.0502320102
50. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25(12):1696-1708. doi: 10.1038/sj.onc.1209327
51. Jiao J, Hindoyan A, Wang S, Tran LM, Goldstein AS, Lawson D, Chen D, Li Y, Guo C, Zhang B, Fazli L, Gleave M, Witte ON, Garraway IP, Wu H (2012) Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells. PLoS One 7(8):e42564. doi: 10.1371/journal.pone.0042564
52. Chen Y, Zhao J, Luo Y, Wang Y, Wei N, Jiang Y (2012) Isolation and identification of cancer stem-like cells from side population of human prostate cancer cells. J Huazhong Univ Sci Technolog Med Sci 32(5):697-703. doi: 10.1007/s11596-012-1020-8
53. Burger PE, Gupta R, Xiong X, Ontiveros CS, Salm SN, Moscatelli D, Wilson EL (2009) High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 27(9):2220-2228. doi: 10.1002/stem.135
54. Lukacs RU, Goldstein AS, Lawson DA, Cheng D, Witte ON (2010) Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 5(4):702-713. doi: 10.1038/nprot.2010.11
55. Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG (2012) The PSA(-/lo) prostate cancer cell population harbors selfrenewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 10(5):556-569. doi: 10.1016/j.stem.2012.03.009
56. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON (2007) Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci U S A 104(1):181-186. doi: 10.1073/pnas.0609684104
57. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON (2007) Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25(11):2760-2769. doi: 10.1634/stemcells.2007-0355
58. Lukacs RU, Lawson DA, Xin L, Zong Y, Garraway I, Goldstein AS, Memarzadeh S, Witte ON (2008) Epithelial stem cells of the prostate and their role in cancer progression. Cold Spring Harb Symp Quant Biol 73:491-502. doi: 10.1101/sqb.2008.73.012
59. Cunha GR, Lung B (1978) The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J Exp Zool 205(2):181-193. doi: 10.1002/jez.1402050203
60. Xin L, Ide H, Kim Y, Dubey P, Witte ON (2003) In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci U S A 100(Suppl 1):11896-11903. doi: 10.1073/pnas.1734139100